Company signals · MedTech
HistoSonics
1 signal in the current window, with MitchelLake's leadership read on each.
Last updated
Market context: Against a Talent Market Index of 111.4 (Hot) (up 5.2 month-on-month), Asia is at rising (+3.7pts) on signal share.
HistoSonics: 1 signal in the last 90 days — in line with the MedTech median of 1 across 21 tracked companies; 0.1% of MitchelLake's Asia signal flow.
Signals at HistoSonics
MitchelLake in this thematic
More signals across MedTech
Geographic Expansion · Asia
Stryker →Stryker has established APAC operations with dedicated VP and General Manager role, indicating significant regional investment in medical technologies
Partnership · Asia
ZEISS Medical Technology →ZEISS Medical Technology signed a strategic agreement with Aier Eye Hospital Group for purchase and installation of 25 ZEISS VISUMAX 800 femtosecond lasers across multiple locations
Geographic Expansion · Oceania
Dedalus →Dedalus is expanding its diagnostic imaging portfolio into Australia and has appointed a senior business lead to drive the initiative
Partnership · Americas
Olympus Corporation →Olympus Corporation announced a 3-year reseller agreement in May 2026 making First Nation Group an authorized Service-Disabled Veteran-Owned Small Business reseller. This partnership provides federal healthcare providers streamlined access to Olympus capital equipment and single-use medical devices across gastroenterology, urology, respiratory and surgical specialties.
Leadership Change · Americas
Illumina →Illumina appoints Daniel M. Skovronsky, Chief Scientific and Product Officer at Eli Lilly and President of Lilly Research Laboratories, to its Board of Directors, effective June 16, 2026.
Intelligence powered by Autonodal ↗